Dergiler / Eurasian Journal of Medical Investigation / 2021 / Cilt: 5 - Sayı: 2

Can Neutrophil-To-Lymphocyte Ratio or Platelet-To Lymphocyte Ratio Predict Chemotherapy Response inTesticular Cancer?

Sayfa
269–273
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

This rela tionship can be supported by further studies.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: The relationships of NLR (neutrophil lymphocyte ratio) and PLR (platelet lymphocyte ratio) with treatmentresponse and prognosis of many types of cancer have been previously investigated.
📊
Temel Bulgular & Veri:Methods: The data of 40 patients with testicular cancer (TCa) who were followed at our center between 2017-2020and received 3-4 cycles of BEP protocol were retrospectively screened and included who met the criteria for inclusionin the study.
💡
Sonuç & Katkı:This rela tionship can be supported by further studies.
🔬Tür:Araştırma Makalesi
📍Kapsam:2017 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objectives: The relationships of NLR (neutrophil lymphocyte ratio) and PLR (platelet lymphocyte ratio) with treatmentresponse and prognosis of many types of cancer have been previously investigated. However, there is no study in theliterature about the relationship of NLR and PLR with treatment response in testicular germ cell tumors (GCTs). Weaimed to investigate the relationship between pre-treatment NLR and PLR values with treatment response and prog nosis in patients with testicular GCT. Methods: The data of 40 patients with testicular cancer (TCa) who were followed at our center between 2017-2020and received 3-4 cycles of BEP protocol were retrospectively screened and included who met the criteria for inclusionin the study. Results: Complete response (CR) to chemotherapy was obtained in 57.5% of the patients, and partial response (PR)was obtained in 35% of the patients. In comparison to the CR group, the mean NLR values were significantly higher inthe non-CR group (p=0.02). Mean PLR values were also significantly higher in the non-CR group (p=0.026). Statisticallysignificant positive correlations were found between tumor stage and NLR & PLR values (r=0.505, p=0.001 for NLR;r=0.397, p=0.011 for PLR). A statistically significant positive correlation was found between tumor stage and neutrophillevel (r=0.365, p=0.020), while a statistically significant negative correlation was found between tumor stage and lym phocyte level (r=-0.314, p=0.048). Conclusion: In the present study we found a correlation between high NLR and PLR values and low CR rates. This rela tionship can be supported by further studies.

🔖

Bu Makaleye Atıf Yap

KARADAĞ, İ., KARAKAYA, S., ATEŞ, Ö., ÖKSÜZOĞLU, O. B. C. (2022). Can Neutrophil-To-Lymphocyte Ratio or Platelet-To Lymphocyte Ratio Predict Chemotherapy Response inTesticular Cancer?. Eurasian Journal of Medical Investigation, Cilt: 5 - Sayı: 2, 269–273. https://ajindex.com/articles/508612

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. SEER Cancer Statistics Fact sheets: Testicular Cancer. Bethesda, MD: National Cancer Institute; 2019
  2. Hanna NH, Einhorn LH. Testicularcancer—discoveriesandupdates. N Engl J Med 2014;371:2005–16
  3. Feng JF, Huang Y, Chen QX. Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma. World J Surg Oncol 2014;12:58
  4. Templeton AJ, Ace O, McNamara MG, Al-Mubarak M, VeraBadillo FE, Hermanns T et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and metaanalysis. Cancer Epidemiol Biomarkers Prev 2014;23:1204–12
  5. Chen H, He J. Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after radical resection of esophageal squamous cell carcinoma. Zhonghua Zhong Liu Za Zhi 2014;36:294–7
  6. Smith RA, Ghaneh P, Sutton R, Raraty M, Campbell F, Neoptolemos JP. Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet–lymphocyte ratio. J Gastrointest Surg. 2008;12:1422–8
  7. Stotz M, Gerger A, Eisner F, Szkandera J, LoibnerH, Ress AL, et al. Increased neutrophil–lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer 2013;109:416–21 8. Yodying H, Matsuda A, Miyashita M, Matsumoto S, Sakurazawa N, Yamada M, et al. Prognostic significance of neutrophilto-lymphocyte ratio and platelet-to-lymphocyte ratio in oncologic outcomes of esophageal cancer: a systematic review and meta-analysis. Ann Surg Oncol 2016;23:646–54
  8. Zhao QT, Yuan Z, Zhang H, Zhang XP, Wang HE, Wang ZK, et al. Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients. Int J Cancer 2016;139:164–70
  9. Lu C, Gao P, Yang Y, Chen X, Wang L, Yu D, et al. Prognostic evaluation of platelet to lymphocyte ratio in patients with colorectal cancer. Oncotarget 2017;8:86287–95
  10. Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol 2014;15:e493–503
  11. Roxburgh CS, McMillan DC. Cancer and systemic inflammation: treat the tumour and treat the host. Br J Cancer 2014;110:1409–12
  12. Zhao Z, Zhao X, Lu J, Xue J, Liu P, Mao H. Prognostic roles of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in ovarian cancer: a meta-analysis of retrospective studies. Arch Gynecol Obstet 2018;29:849–57. 1